Circulating tumor cells (CTCs) represent an interesting source of biomarkers for diagnosis,
prognosis, and the prediction of cancer recurrence, yet while they are extensively studied in …

Circulating tumor cells (CTCs) have received a great deal of scientific and clinical attention
as a biomarker for diagnosis and prognosis of many types of cancer. Given their potential …

Circulating tumor cells (CTCs) are a hallmark of invasive behavior of cancer, responsible for
the development of metastasis. Their detection and analysis have significant impacts in …

Cancer is one of the leading causes of noncommunicable disease-related mortality
worldwide. Recent estimates show that 90% of cancer-related deaths are caused by …

Circulating tumour cells (CTCs) have recently been identified as valuable biomarkers for
diagnostic and prognostic evaluations, as well for monitoring therapeutic responses to …

Circulating tumor cells (CTCs) are cancer cells that shed from a primary tumor and circulate
in the bloodstream. As a form of “tumor liquid biopsy”, CTCs provide important information …

Metastasis is the main cause of death in cancer patients worldwide. During metastasis,
cancer cells detach from the primary tumor and invade distant tissue. The cells that undergo …

Circulating tumor cells (CTCs) are cancer cells that are shed from a primary tumor into the
bloodstream and function as seeds for cancer metastasis at distant locations. Enrichment …

Cancer stem cells with stem-cell properties are regarded as tumor initiating cells. Sharing
stem-cell properties, circulating tumor cells (CTCs) are responsible for the development of …

BACKGROUND One of the objectives for the liquid biopsy is to become a surrogate to tissue
biopsies in diagnosis of cancer as a minimally invasive method, with clinical utility in real …